KANUMA
Concentrate for solution for infusion, 2mg/ml
RxActive license
Active substance (INN)
sebelipase alfa
Pharmaceutical form
Pharmaceutical formConcentrate for solution for infusion
Strength2mg/ml
PackagingUkupno 1 bočica staklena sa 10ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerAlexion Pharma International Operations Limited, Ireland
Therapeutic groupAlimentary tract and metabolism (A16AB14)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateApril 1, 2025
Source: CInMED register